Jyothy Labs Confirms Non-Renewal of Pril and Fa License Agreements with Henkel
Jyothy Labs Ltd. has announced that Henkel AG & Co. KGaA has decided not to renew the License Agreements and Technology License Agreements governing the manufacture, distribution, marketing, and sale of the brands Pril and Fa. The agreements, which were originally executed on May 31, 2011, contained automatic renewal provisions extending until May 31, 2026.The non-renewal decision follows discussions between the Company and Henkel, concluding that there is no further reasonable possibility of extending the existing agreements beyond the specified date.
The original collaboration centered on the Pril and Fa brands and involved Henkel AG & Co. KGaA and the Company, represented by Erstwhile Henkel India Limited (since amalgamated with Jyothy Labs Limited).
The key details regarding the agreements are summarized below:
| Particulars | Details |
|---|---|
| Parties Involved | Erstwhile Henkel India Limited and Henkel AG & Co. KGaA |
| Nature of Agreement | License Agreements and Technology License Agreements |
| Purpose | Manufacturing, distribution, marketing, and sale under Pril and Fa brands |
| Original Execution Date | May 31, 2011 |
| Status of Agreement | Agreements may stand non-renewed beyond May 31, 2026 |
Following the realization of the non-renewal of the agreements, the Company’s board of directors held a meeting and initiated an evaluation of all available options. The company stated that the financial impact resulting from the non-renewal is currently under evaluation. Jyothy Labs Ltd. remains committed to promptly disclosing any material developments regarding the situation.
JYOTHYLAB Stock Price Movement
On Friday, Jyothy Labs Limited shares edged higher to close at ₹261.40, having gained 0.97% for the trading session. The stock traded on a volume of 286,758 shares, signaling robust buying interest as it settled near the upper end of its daily range.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.